In the BioHarmony Drug Report Database

"Preview" Icon

Ceftaroline fosamil

Teflaro, Zinforo (ceftaroline fosamil) is a small molecule pharmaceutical. Ceftaroline fosamil was first approved as Teflaro on 2010-10-29. It is used to treat escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, and staphylococcal infections amongst others in the USA. It has been approved in Europe to treat community-acquired infections, infectious skin diseases, and pneumonia. Teflaro’s patents are valid until 2031-02-10 (FDA).

 

Trade Name

 

Zinforo
 

Common Name

 

ceftaroline fosamil
 

ChEMBL ID

 

CHEMBL501122
 

Indication

 

community-acquired infections, escherichia coli infections, infectious skin diseases, klebsiella infections, pneumonia, staphylococcal infections, streptococcal infections
 

Drug Class

 

Cephalosporins; phosphoro-derivatives

Image (chem structure or protein)

Ceftaroline fosamil structure rendering